This invention is a computational system that generates high-resolution synthetic populations representing individuals, households, and their socioeconomic characteristics for the entire United States.

This technology utilizes the osmocapillary effect in a swollen polymer network to generate adhesion.

This invention is an advanced clinical decision support system that utilizes machine learning to determine optimal radiotherapy doses and predict survival outcomes for patients undergoing brain radiosurgery.

University of Pittsburgh researchers have developed a novel biofluid biomarker to identify early-stage pre-tangle tau aggregates.

University of Pittsburgh researchers have developed an evidence-based teaching course, Critical Conversations, to provide serious illness communications skills training to clinicians.

University of Pittsburgh and University of Pennsylvania researchers have designed and synthesized a series of substituted–indoles as positron emission tomography (PET) radiotracers for use in imaging 4-repeat tau (4R-tau) in non-Alzheimer’s disease (AD) tauopathies.

This invention introduces novel solutions and methods for machine perfusion to significantly improve organ preservation.

University of Pittsburgh researchers have developed an imaging method that tracks individual red blood cells (RBC) as they move through the tiniest blood vessels in the eye, without dyes, contrast agents, or specialized adaptive optics.

A University of Pittsburgh researcher has developed a human brain-computer interface platform.

This invention comprises a set of proprietary cell lines that model aggressive Acute Myeloid Leukemia (AML) by expressing constitutively active forms of the myeloid Src-family kinases, Fgr and Hck.

University of Pittsburgh researchers have developed a serological biomarker test for the risk prediction of Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma (NPC).

The Knowledge of Effective Parenting Test (KEPT) is an assessment system that uses realistic, scenario-based questions to objectively measure how well parents understand the parenting skills taught in evidence-based behavioral and cognitive-behavioral programs.

This technology is a computational framework that uses gene expression and protein data from blood immune cells to estimate a patient's biological "immune recovery time" and compare it against actual time since injury or illness onset.

This is a novel, non-systemic hydrogel comprising a proprietary conjugate of Hyaluronic Acid and Metformin.

Researchers at the University of Pittsburgh have developed a novel microneedle array (MNA) technology for the delivery of adenovirus vectored vaccines, both with and without adjuvants.